Annual CAPEX
N/A
December 31, 2023
Summary
- KPTI annual capital expenditures is not available.
Performance
KPTI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly capital expenditures is $0.00, unchanged on September 30, 2024.
- Over the past year, KPTI quarterly CAPEX has stayed the same.
- KPTI quarterly CAPEX is now -100.00% below its all-time high of $6.00 million, reached on September 30, 2021.
Performance
KPTI Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$195.00 K
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, KPTI TTM capital expenditures is $195.00 thousand, unchanged on September 30, 2024.
- Over the past year, KPTI TTM CAPEX has stayed the same.
- KPTI TTM CAPEX is now -96.82% below its all-time high of $6.12 million, reached on September 30, 2021.
Performance
KPTI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
KPTI CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | 0.0% | 0.0% |
| 3 y3 years | - | -100.0% | -96.8% |
| 5 y5 years | - | -100.0% | -5.3% |
KPTI CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | +100.0% | -96.6% | +211.4% | ||
| 5 y | 5-year | -100.0% | +100.0% | -96.8% | +211.4% | ||
| alltime | all time | -100.0% | +100.0% | -96.8% | +211.4% |
Karyopharm Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $195.00 K(0.0%) |
| Jun 2024 | - | $0.00(-100.0%) | $195.00 K(0.0%) |
| Mar 2024 | - | $195.00 K(>+9900.0%) | $195.00 K(+65.3%) |
| Dec 2022 | $118.00 K(-97.9%) | $0.00(-100.0%) | $118.00 K(-167.4%) |
| Sep 2022 | - | $39.00 K(>+9900.0%) | -$175.00 K(-103.0%) |
| Jun 2022 | - | $0.00(-100.0%) | $5.79 M(0.0%) |
| Mar 2022 | - | $79.00 K(-127.0%) | $5.79 M(+1.4%) |
| Dec 2021 | $5.71 M(+3839.3%) | -$293.00 K(-104.9%) | $5.71 M(-6.7%) |
| Sep 2021 | - | $6.00 M(+4946.2%) | $6.12 M(+4123.4%) |
| Dec 2020 | $145.00 K(-29.6%) | $119.00 K(>+9900.0%) | $145.00 K(+90.8%) |
| Sep 2020 | - | $0.00(-100.0%) | $76.00 K(-58.5%) |
| Jun 2020 | - | $16.00 K(+60.0%) | $183.00 K(+9.6%) |
| Mar 2020 | - | $10.00 K(-80.0%) | $167.00 K(-18.9%) |
| Dec 2019 | $206.00 K(-91.3%) | $50.00 K(-53.3%) | $206.00 K(-83.5%) |
| Sep 2019 | - | $107.00 K(>+9900.0%) | $1.25 M(-23.5%) |
| Jun 2019 | - | $0.00(-100.0%) | $1.63 M(-19.6%) |
| Mar 2019 | - | $49.00 K(-95.5%) | $2.03 M(-14.1%) |
| Dec 2018 | $2.36 M | $1.09 M(+122.6%) | $2.36 M(+78.3%) |
| Sep 2018 | - | $491.00 K(+23.7%) | $1.32 M(+57.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $397.00 K(+3.9%) | $841.00 K(+89.4%) |
| Mar 2018 | - | $382.00 K(+594.5%) | $444.00 K(+616.1%) |
| Dec 2017 | $62.00 K(-11.4%) | $55.00 K(+685.7%) | $62.00 K(+93.8%) |
| Sep 2017 | - | $7000.00(-72.0%) | $32.00 K(-54.3%) |
| Dec 2016 | $70.00 K(-95.1%) | $25.00 K(>+9900.0%) | $70.00 K(-87.3%) |
| Sep 2016 | - | $0.00(-100.0%) | $550.00 K(-19.9%) |
| Jun 2016 | - | $6000.00(-84.6%) | $687.00 K(-46.2%) |
| Mar 2016 | - | $39.00 K(-92.3%) | $1.28 M(-9.8%) |
| Dec 2015 | $1.42 M(-50.0%) | $505.00 K(+268.6%) | $1.42 M(+40.2%) |
| Sep 2015 | - | $137.00 K(-77.0%) | $1.01 M(-68.0%) |
| Jun 2015 | - | $596.00 K(+234.8%) | $3.16 M(+9.4%) |
| Mar 2015 | - | $178.00 K(+79.8%) | $2.89 M(+1.9%) |
| Dec 2014 | $2.83 M(+4871.9%) | $99.00 K(-95.7%) | $2.83 M(+2.4%) |
| Sep 2014 | - | $2.29 M(+605.6%) | $2.77 M(+446.8%) |
| Jun 2014 | - | $324.00 K(+159.2%) | $506.00 K(+178.0%) |
| Mar 2014 | - | $125.00 K(+290.6%) | $182.00 K(+219.3%) |
| Dec 2013 | $57.00 K(-52.9%) | $32.00 K(+28.0%) | $57.00 K(+128.0%) |
| Sep 2013 | - | $25.00 K | $25.00 K |
| Dec 2012 | $121.00 K(-67.8%) | - | - |
| Dec 2011 | $376.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly CAPEX year-on-year change?
- What is Karyopharm Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics TTM CAPEX year-on-year change?
What is the all time high annual CAPEX for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual capital expenditures is $5.71 M
What is Karyopharm Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of KPTI is $0.00
What is the all time high quarterly CAPEX for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly capital expenditures is $6.00 M
What is Karyopharm Therapeutics quarterly CAPEX year-on-year change?
Over the past year, KPTI quarterly capital expenditures has changed by $0.00 (0.00%)
What is Karyopharm Therapeutics TTM capital expenditures?
The current TTM CAPEX of KPTI is $195.00 K
What is the all time high TTM CAPEX for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM capital expenditures is $6.12 M
What is Karyopharm Therapeutics TTM CAPEX year-on-year change?
Over the past year, KPTI TTM capital expenditures has changed by $0.00 (0.00%)